Back to top
more

Addus HomeCare (ADUS)

(Real Time Quote from BATS)

$106.15 USD

106.15
34,474

+1.19 (1.13%)

Updated Aug 4, 2025 01:08 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (62 out of 246)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Encompass Health Expands Partnership With Piedmont in Georgia

by Zacks Equity Research

EHC and Piedmont expand their partnership with a new rehab hospital in Athens, enhancing patient recovery services.

Zacks Equity Research

Molina Healthcare Expands Presence With Illinois D-SNP Contract Win

by Zacks Equity Research

MOH secures a key Illinois contract, strengthening its foothold in the dual-eligible market.

Harshit Gupta headshot

AVAH Surges 45% in Five Days: How to Play the Stock After Earnings?

by Harshit Gupta

AVAH trades at a discount despite growth in payor deals & services. With solid fundamentals amid labor shortages, is it a buy or hold after earnings?

Zacks Equity Research

ADUS vs. USPH: Which Stock Is the Better Value Option?

by Zacks Equity Research

ADUS vs. USPH: Which Stock Is the Better Value Option?

Zacks Equity Research

Humana & Icon Enhance Senior Healthcare With Integrated Specialty Care

by Zacks Equity Research

HUM's CenterWell and Conviva partner with Icon Health, improving musculoskeletal care access for seniors.

Zacks Equity Research

Are Investors Undervaluing Addus HomeCare (ADUS) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Teladoc Expands Specialty Care Access With Carrum Health Partnership

by Zacks Equity Research

TDOC partners with Carrum Health in a bid to expand access to specialty care.

Zacks Equity Research

Here's What Brookdale's Occupancy Growth Story Tells Us

by Zacks Equity Research

BKD is likely to have witnessed 40 straight months of year-over-year increases in weighted average occupancy.

Zacks Equity Research

Teladoc Doubles Down on Connected Care With New Partnerships

by Zacks Equity Research

With more than 93 million members, deeper integration of services could lead to higher utilization for TDOC.

Zacks Equity Research

Is the Options Market Predicting a Spike in Addus HomeCare (ADUS) Stock?

by Zacks Equity Research

Investors need to pay close attention to Addus HomeCare (ADUS) stock based on the movements in the options market lately.

Zacks Equity Research

Here's Why Community Health's Florida Divestiture Matters

by Zacks Equity Research

Offloading the Punta Gorda facility is expected to remove uncertainty tied to restoration costs and revenue losses for CYH.

Zacks Equity Research

ADUS or USPH: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

ADUS vs. USPH: Which Stock Is the Better Value Option?

Zacks Equity Research

Here's What Key Metrics Tell Us About Addus HomeCare (ADUS) Q4 Earnings

by Zacks Equity Research

While the top- and bottom-line numbers for Addus HomeCare (ADUS) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Equity Research

Addus HomeCare (ADUS) Q4 Earnings Match Estimates

by Zacks Equity Research

Addus HomeCare (ADUS) delivered earnings and revenue surprises of 0% and 1.71%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Down -16.38% in 4 Weeks, Here's Why You Should You Buy the Dip in Addus HomeCare (ADUS)

by Zacks Equity Research

Addus HomeCare (ADUS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Zacks Equity Research

3 Reasons Why Growth Investors Shouldn't Overlook Addus HomeCare (ADUS)

by Zacks Equity Research

Addus HomeCare (ADUS) possesses solid growth attributes, which could help it handily outperform the market.

Zacks Equity Research

Should Value Investors Buy Addus HomeCare (ADUS) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Zacks.com featured highlights Deckers Outdoor, Boot Barn, Addus HomeCare and The Ensign Group

by Zacks Equity Research

Deckers Outdoor, Boot Barn, Addus HomeCare and The Ensign Group have been highlighted in this Screen of The Week article.

Sumit Singh headshot

Pick These 4 Stocks With Impressive Interest Coverage Ratios

by Sumit Singh

DECK, BOOT, ADUS & ENSG's impressive interest coverage ratios highlight that these companies can withstand financial hardships.

Zacks Equity Research

Ahead of Addus HomeCare (ADUS) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

by Zacks Equity Research

Besides Wall Street's top -and-bottom-line estimates for Addus HomeCare (ADUS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2024.

Zacks Equity Research

ADUS vs. CHE: Which Stock Is the Better Value Option?

by Zacks Equity Research

ADUS vs. CHE: Which Stock Is the Better Value Option?

Zacks Equity Research

DVA Q4 Estimates Unchanged Before Earnings: How to Play the Stock?

by Zacks Equity Research

Continued strength in RPT is likely to have boosted DaVita's top line in the fourth quarter despite supply challenges weighing on its performance.

Zacks Equity Research

ADUS or USPH: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

ADUS vs. USPH: Which Stock Is the Better Value Option?

Zacks Equity Research

Are Medical Stocks Lagging Addus HomeCare (ADUS) This Year?

by Zacks Equity Research

Here is how Addus HomeCare (ADUS) and Arcutis Biotherapeutics, Inc. (ARQT) have performed compared to their sector so far this year.

Zacks Equity Research

Zacks Industry Outlook Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare

by Zacks Equity Research

Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare have been highlighted in this Industry Outlook article.